Local importer to stop bringing in imitation Viagra
PHARMACEUTICAL company Pfizer has reached a settlement with a local importer for him to cease importation of an imitator product of the drug Viagra.
Pfizer stated in a release on Tuesday a settlement had been reached with Mohammed Baig whereby he had agreed to cease any and all further importation of a Viagra imitator product Kamagra.
Pfizer reported that last year the High Court in Trinidad issued an injunction against Baig prohibiting the importation and distribution of Kamagra, which Pfizer had alleged infringed its Trinidad patent on Viagra.
Kamagra contains the drug compound sildenafil which is also the active ingredient in Pfizer’s Viagra, an oral medication used to treat erectile dysfunction.
Pfizer noted that the Court also ordered that a shipment of the infringing drug which had been consigned to Baig, but had been seized and held by the Customs and Excise Division, be delivered to Pfizer for destruction.
Pfizer is the world’s largest research-based biomedical and pharmaceutical company, and it discovers, develops, manufactures, and markets leading prescription medicines. Its corporate headquarters are located in New York.
Related posts:
- Pfizer gives Viagra to jobless during hard times
- Illegal sale of sexual enhancement tablets
- Pfizer’s future tied to biotechnology
- Businessman’s Viagra sex pills probe
- FDA to review NexMed NDA for erectile dysfunction drug
Comments
Leave a Reply